agilon health (NYSE:AGL) Shares Up 3.6% – What’s Next?

agilon health, inc. (NYSE:AGL) shares were up 3.6% during trading on Friday . The company traded as high as $4.07 and last traded at $4.15. Approximately 533,432 shares were traded during trading, a decline of 88% from the average daily volume of 4,608,505 shares. The stock had previously closed at $4.00.

Analysts Set New Price Targets

A number of brokerages recently issued reports on AGL. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Stifel Nicolaus boosted their target price on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th. Royal Bank of Canada raised their price target on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Sanford C. Bernstein boosted their price objective on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Finally, Macquarie began coverage on shares of agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price on the stock. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $3.95.

agilon health Price Performance

The firm has a 50-day simple moving average of $3.73 and a 200-day simple moving average of $3.00. The firm has a market cap of $1.70 billion, a P/E ratio of -4.34 and a beta of 0.67. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

Institutional Investors Weigh In On agilon health

Institutional investors have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. grew its holdings in agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after purchasing an additional 1,083,492 shares during the last quarter. Inspire Investing LLC grew its stake in agilon health by 106.6% during the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after buying an additional 112,241 shares during the last quarter. Geode Capital Management LLC increased its position in agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after buying an additional 84,889 shares in the last quarter. Empowered Funds LLC purchased a new stake in agilon health in the fourth quarter valued at about $97,000. Finally, Handelsbanken Fonder AB boosted its holdings in agilon health by 47.9% in the fourth quarter. Handelsbanken Fonder AB now owns 75,000 shares of the company’s stock worth $142,000 after acquiring an additional 24,300 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.